Market Overview

According to Fortune Business Insights, the global oxygen concentrator devices market size was valued at USD 5.24 billion in 2025. The market is projected to grow from USD 5.58 billion in 2026 to USD 9.25 billion by 2034, exhibiting a CAGR of 6.51% during the forecast period. North America dominated the oxygen concentrator devices market with a market share of 35% in 2025.

Fortune Business Insights™ has deep-dived into these insights in its latest research report, titled “Oxygen Concentrator Devices Market, 2026-2034.”

The analysis shows that healthcare providers and patients are increasingly adopting oxygen concentrators as a reliable, cost-effective alternative to traditional compressed oxygen cylinders across hospitals, homecare, and emergency settings. For example, technological improvements in sieve materials, compressors, and power efficiency have significantly enhanced device reliability and patient mobility, accelerating the integration of concentrators into decentralized home healthcare models. This trend indicates a strong demand for oxygen concentrator devices worldwide.

Major Players Profiled in the Market Report:

• Invacare Corporation
• Inogen
• GCE Healthcare
• CAIRE Inc.
• Drive DeVilbiss International
• O2 Concepts
• Nidek Medical Products
• Precision Medical
• Besco Medical

Segments

Growing Demand for Mobility-Oriented Therapy to Propel Portable Oxygen Concentrators Segment Growth

Based on type, the market is divided into portable oxygen concentrators and stationary oxygen concentrators. The portable oxygen concentrators segment holds the largest market share at approximately 55% and dominates the market owing to growing demand for mobility-oriented oxygen therapy, lightweight and airline-approved designs, rechargeable battery systems, and the ongoing shift toward home healthcare and outpatient respiratory management.

Need for Uninterrupted Oxygen Supply in Critical Care to Drive Continuous Flow Segment Expansion

By delivery system, the market is categorized into continuous flow and pulse flow. The continuous flow segment is leading the market, accounting for approximately 60% of the market share, as it provides a constant supply of oxygen regardless of breathing patterns—making it essential for hospitals, intensive care units, sleep therapy, and patients managing severe chronic respiratory diseases.

Rising Need for Long-Term Hypoxemia Management to Propel COPD Segment Growth